Matrix metalloproteinases (MMPs) mediate cell migration and tissue remodeling and are important in cardiac development. We examined the expression patterns of two MMP inhibitors, tissue inhibitor of metalloproteinase (TIMP)-2 and TIMP-3, during critical stages of cardiac development. Both TIMP-2 and TIMP-3 mRNA were expressed in the endocardium prior to and during early cushion cell formation. TIMP-2 was continually expressed within the outflow tract (OT) and atrioventricular (AV) cushion cells at all stages examined, whereas TIMP-3 mRNA was undetectable in the AV cushion cells soon after their formation. Subsequently, TIMP-3 mRNA disappeared in cushion cells of the distal OT and this loss progressed toward the ventricle until eventually all of the OT cushion cells lacked detectable TIMP-3 transcripts. TIMP-3, but not TIMP-2, was also expressed within remodeling myocardium. Immunocytochemistry confirmed these findings. These observations suggest that TIMP-2 and TIMP-3 have important but unique roles in early cardiac development. q
Introduction
The embryonic heart begins as a linear tubular structure and is remodeled into an S-shaped tube that develops muscular septa. Further remodeling is needed for widening the conal outlet and aligning the atrioventricular (AV) canals with the ventricles before septation is complete. Cardiac septation also requires the formation and migration of cushion cells generated by an epithelial-mesenchymal transformation in the AV and outflow tract (OT) regions as well as invasion of neural crest cells (Kirby, 1987; Mjaatvedt et al., 1999; Sumida et al., 1989) .
Matrix metalloproteinases (MMPs) likely play important roles in the development of the embryonic heart (Alexander et al., 1997; Cai et al., 2000; Song et al., 2000) . Tissue inhibitor of metalloproteinases (TIMPs), secreted by cells, inhibit MMP activity and can mediate MMP-dependent cell migration, invasion, and tissue remodeling (Blavier and DeClerck, 1997; Brew et al., 2000; Henriet et al., 1999) . TIMP-2 and TIMP-3 mRNA transcripts, but not TIMP-1, have been detected in hearts (Apte et al., 1997; Blavier and DeClerck, 1997; Nomura et al., 1989) but the specific temporal and spatial pattern of TIMP expression during the early critical stages of embryonic heart development is not known. That was the purpose of this study.
Results and discussion
TIMP-2 mRNA was first detected in the endocardium of Hamburger-Hamilton stage 12 chick hearts (Fig. 1A) and then expanded to include the aortic sac endothelium and the surrounding mesenchyme (Fig. 1B) . With the onset of cushion cell formation, TIMP-2 mRNA was also detected in the AV (Fig. 1C) and OT cushion cells. During subsequent stages, TIMP-2 was continually expressed in these cushion cells and within the epicardium (Fig. 1D-F) . TIMP-2 mRNA was not detected in the myocardium during the stages examined. No signal was detected in sense controls (Fig. 1G ). TIMP-2 immunostaining paralleled the mRNA expression with the exception that the myocardium was (Fig. 1H) suggesting the possibility that the myocardium may synthesize steady but undetectable levels of mRNA, the mRNA may have a much shorter half-life than the protein in the myocardium, or TIMP-2 protein secreted by the endocardium and cushion cells accumulated on the myocardium. No immunostaining was detected in controls ( Fig. 1I ).
TIMP-3 mRNA transcripts were first detected in the noto- chord at stage 8. Beginning at stages 11-12, TIMP-3 mRNA expression was then detected within the myocardium of the OT ( Fig. 2A,B) and by stage 13, included the entire endocardium and some atrial myocardium adjoining the AV canal (Fig. 2C) . With the onset of cushion cell formation, TIMP-3 mRNA was detected in the AV and OT endocardium and their cushion cells (Fig. 2D) . By stage 19, TIMP-3 transcripts were no longer detected in the AV and proximal conal endocardium or in AV cushion cells but coincidentally appeared within the adjacent myocardium (Fig. 2E) . In the OT, TIMP-3 expression in the cushion cells began disappearing at the truncal end of stage 21-22 embryos and loss of expression advanced proximally toward the ventricle so that by stage 25, TIMP-3 was no longer detected in OT cushion cells (Fig. 2F,G ). This correlates with the invasion of neural crest cells into the OT (Poelmann et al., 1998; Waldo et al., 1998) . However, TIMP-3 mRNA expression continued in the OT endocardium and AV myocardium at least until stage 25 (Fig. 2G,H) . No signal was detected in sense controls (Fig. 2I ). TIMP-3 immunostaining confirmed these results (Fig. 2J,K) . Interestingly, TIMP-3 immunostaining was more intense in areas of myocardial remodeling including the AV canal ( Fig. 2K ) and ventricular trabeculae. It was also more intense within the proximal conal myocardium opposite the AV region than elsewhere in the conus (Fig. 2K) . No immunostaining was observed in controls (Fig. 2L) . Hence, TIMP-3 expression positively correlated with remodeling events leading to separation of the atrial and ventricular myocardium and realignment of the AV canal's OT with the developing ventricles (Mjaatvedt et al., 1999) . Collectively, these expression patterns suggest that TIMP-2 and TIMP-3 have important but differing roles in early cardiac development with TIMP-2 being predominantly associated with continued cardiac cushion development and TIMP-3 being predominantly associated with myocardial remodeling.
Experimental procedures
Digoxigenin-labeled sense and antisense riboprobes were generated from chicken TIMP-2 cDNA (provided by James P. Quigley, Scripps Institute, La Jolla, CA; Aimes et al., 1998) and chicken TIMP-3 cDNA was obtained using chicken RNA, reverse transcription-polymerase chain reaction, and primers based on the chicken TIMP-3 sequence (Pavloff et al., 1992) . Whole-mount in situ hybridization was performed on Hamburger-Hamilton stage 8-25 chick embryos as previously described (Cai et al., 2000) .
For immunolocalization, embryos were fixed for 1 h in 100% acetone and frozen sections prepared. Sections were incubated with human TIMP-2 or TIMP-3 monoclonal antibody (Chemicon International, Inc., Temecula, CA) and binding was detected using rabbit anti-mouse Fab 0 fragments and donkey anti-rabbit-fluorescein isothiocyanate (Jackson ImmunoResearch Laboratories, West Grove, PA). Controls included omission of the first antibody, substituting primary antibody with non-immune IgG, and preabsorbing the primary antibody with human TIMP-2 or TIMP-3.
